Press Releases

Nov 6, 2019

New data to be presented at ASH 2019 highlight Sanofi's commitment to treat challenging blood cancers and rare blood disorders

*Oncology: New data from investigational isatuximab pivotal study for the treatment of relapsed/refractory multiple myeloma
Nov 6, 2019

New data for isatuximab in multiple myeloma to be presented at ASH 2019
Nov 4, 2019

FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older

* Will be available in fall 2020, in time for the 2020-2021 flu season
Nov 4, 2019

Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes
Oct 31, 2019

Sanofi Q3 well on track
- Video 1
- Photos 4

Show per page

Print
Email page
RSS